A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study
- PMID: 10841122
- DOI: 10.1016/s0140-6736(00)82008-5
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study
Erratum in
- Lancet 2000 Apr 15;355(9212):1372
Abstract
Background: Women with small mammographically detected breast cancers generally have good long-term outcomes, but a few with T1a (1-5 mm) and T1b (6-10 mm) tumours will eventually die from breast cancer. We investigated whether women at high risk of breast-cancer death could be identified with mammographic criteria and differentiated from women with small cancers of the breast and good outcomes.
Methods: We prospectively applied mammographic classifications of tumour type to a consecutive series of 343 mammograms of invasive breast cancers of size 1-14 mm. Classifications were: stellate (spiculated) mass with no calcifications; circular or oval lesions with no calcifications; spiculated or circular lesions with non-casting-type calcifications; and casting-type calcifications.
Findings: 20-year survival for women with 1-14 mm invasive tumours with casting-type calcifications was 55%. 14% of 138 women with 1-9 mm tumours had casting-type calcifications on mammography, which accounted for 73% of all breast-cancer deaths (p<0.001). T1a, T1b, and 10-14 mm tumours with casting-type calcifications behaved as if they were larger lesions, since the rate of death was similar to that for women with advanced high-grade tumours. Most women who died were node-negative. The long-term survival of women who had tumours of 1-9 mm with no casting-type calcifications was about 95%.
Interpretation: Mammographic classification seemed to reliably predict good and bad long-term outcomes for survival in tumours of 14 mm or smaller, and especially for those smaller than 10 mm. The implications for therapy are substantial.
Comment in
-
Long-term outcome of invasive breast cancer.Lancet. 2000 Apr 29;355(9214):1551; author reply 1552-3. doi: 10.1016/S0140-6736(00)02178-4. Lancet. 2000. PMID: 10801192 No abstract available.
-
Long-term outcome of invasive breast cancer.Lancet. 2000 Apr 29;355(9214):1551-2; author reply 1552-3. doi: 10.1016/S0140-6736(05)74599-2. Lancet. 2000. PMID: 10801193 No abstract available.
-
Long-term outcome of invasive breast cancer.Lancet. 2000 Apr 29;355(9214):1552; author reply 1552-3. doi: 10.1016/s0140-6736(05)74600-6. Lancet. 2000. PMID: 10801194 No abstract available.
-
Long-term outcome of invasive breast cancer.Lancet. 2000 Apr 29;355(9214):1552; author reply 1552-3. doi: 10.1016/S0140-6736(05)74601-8. Lancet. 2000. PMID: 10801195 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials